We develop biomaterials to detect and treat disease.
Current projects include developing surgical solutions for children with congenital heart defects; theranostics (detection and treatment) for cardiovascular disease and cancer; tissue-engineered and nanoparticle strategies for cardiovascular disease; and nanoparticle reporters for enhanced oil recovery.
We recently published a study testing drug carriers (liposomes) and ultrasound on blood vessels-on-a-chip. This was a collaboration with Nooli Jeon's group at Seoul National University and others where we tested ultrasound-assisted drug delivery in a systematic way.
Our recent work on biased cell migration on gradient-stiffness substrates was published in the Proceedings of the National Academy of Sciences and highlighted as the Top Story in Extracellular Matrix News.